Advanced heart failure: A review

被引:11
作者
Kepinska, Klementyna [1 ]
Adamczak, Daria Maria [2 ]
Kaluzna-Oleksy, Marta [2 ]
机构
[1] Poznan Univ Med Sci, Fac Med, Poznan, Poland
[2] Poznan Univ Med Sci, Fac Med, Dept Cardiol 1, Poznan, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2019年 / 28卷 / 08期
关键词
heart failure; advanced heart failure; stage D; decompensation; PROGNOSTIC-SIGNIFICANCE; AMERICAN-COLLEGE; MORTALITY; RISK; ASSOCIATION; GUIDELINES; STATEMENT; SOCIETY;
D O I
10.17219/acem/103669
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Heart failure (HF) has been recognized as a pandemic and is a serious clinical and health problem associated with significant mortality, morbidity and expenditure on healthcare, especially among older people. Progress in medicine has made it possible for an increasing number of people with HF to live longer than ever before. Therefore, a new and serious clinical problem has appeared - advanced heart failure (AHF). A better understanding of this issue is very important, because there are many more patients waiting for transplantations than there are available hearts. The role of the medical team is to keep the patient in the best condition until the heart transplant/implantation of left ventricular assist devices or at least to ensure the best possible quality of life. This article reviews the available data on AHF. The authors have succinctly presented different definitions and methods of the AHF diagnosis established by medical societies, as well as epidemiological data, methods of assessment, and possible treatment strategies.
引用
收藏
页码:1143 / 1148
页数:6
相关论文
共 26 条
  • [1] Adamowicz J, 2018, EUR J HEART FAIL SS1, V20, P5
  • [2] Identifying Patients Hospitalized With Heart Failure at Risk for Unfavorable Future Quality of Life
    Allen, Larry A.
    Gheorghiade, Mihai
    Reid, Kimberly J.
    Dunlay, Shannon M.
    Chan, Paul S.
    Hauptman, Paul J.
    Zannad, Faiez
    Konstam, Marvin A.
    Spertus, John A.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (04): : 389 - U44
  • [3] Prevalence and prognostic significance of heart failure stages - Application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community
    Ammar, Khawaja Afzal
    Jacobsen, Steven J.
    Mahoney, Douglas W.
    Kors, Jan A.
    Redfield, Margaret M.
    Burnett, John C., Jr.
    Rodeheffer, Richard J.
    [J]. CIRCULATION, 2007, 115 (12) : 1563 - 1570
  • [4] Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial
    Comin-Colet, Josep
    Manito, Nicolas
    Segovia-Cubero, Javier
    Delgado, Juan
    Garcia Pinilla, Jose Manuel
    Almenar, Luis
    Crespo-Leiro, Maria G.
    Sionis, Alessandro
    Blasco, Teresa
    Pascual-Figal, Domingo
    Gonzalez-Vilchez, Francisco
    Luis Lambert-Rodriguez, Jose
    Grau, Maria
    Bruguera, Jordi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (07) : 1128 - 1136
  • [5] Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
    Crespo-Leiro, Maria G.
    Metra, Marco
    Lund, Lars H.
    Milicic, Davor
    Costanzo, Maria Rosa
    Filippatos, Gerasimos
    Gustafsson, Finn
    Tsui, Steven
    Barge-Caballero, Eduardo
    De Jonge, Nicolaas
    Frigerio, Maria
    Hamdan, Righab
    Hasin, Tal
    Huelsmann, Martin
    Nalbantgil, Sanem
    Potena, Luciano
    Bauersachs, Johann
    Gkouziouta, Aggeliki
    Ruhparwar, Arjang
    Ristic, Arsen D.
    Straburzynska-Migaj, Ewa
    McDonagh, Theresa
    Seferovic, Petar
    Ruschitzka, Frank
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (11) : 1505 - 1535
  • [6] Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure
    De Ferrari, Gaetano M.
    Mazzuero, Antonio
    Agnesina, Laura
    Bertoletti, Alessandra
    Lettino, Maddalena
    Campana, Carlo
    Schwartz, Peter J.
    Tavazzi, Luigi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (06) : 550 - 555
  • [7] Evidence-based use of levosimendan in different clinical settings
    De Luca, Leonardo
    Colucci, Wilson S.
    Nieminen, Markku S.
    Massie, Barry M.
    Gheorghiade, Mihai
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (16) : 1908 - 1920
  • [8] Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis
    Echouffo-Tcheugui, Justin B. T.
    Erqou, Sebhat
    Butler, Javed
    Yancy, Clyde W.
    Fonarow, Gregg C.
    [J]. JACC-HEART FAILURE, 2016, 4 (04) : 237 - 248
  • [9] Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee
    Fang, James C.
    Ewald, Gregory A.
    Allen, Larry A.
    Butler, Javed
    Canary, Cheryl A. Westlake
    Colvin-Adams, Monica
    Dickinson, Michael G.
    Levy, Phillip
    Stough, Wendy Gattis
    Sweitzer, Nancy K.
    Teerlink, John R.
    Whellan, David J.
    Albert, Nancy M.
    Krishnamani, Rajan
    Rich, Michael W.
    Walsh, Mary N.
    Bonnell, Mark R.
    Carson, Peter E.
    Chan, Michael C.
    Dries, Daniel L.
    Hernandez, Adrian F.
    Hershberger, Ray E.
    Katz, Stuart D.
    Moore, Stephanie
    Rodgers, Jo E.
    Rogers, Joseph G.
    Vest, Amanda R.
    Givertz, Michael M.
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (06) : 519 - 534
  • [10] Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis
    Fonarow, GC
    Adams, KF
    Abraham, WT
    Yancy, CW
    Boscardin, WJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05): : 572 - 580